Steve Valiquette
Stock Analyst at Barclays
(1.85)
# 3,145
Out of 4,944 analysts
176
Total ratings
45.61%
Success rate
-3.79%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $7.5 → $8 | $7.39 | +8.25% | 5 | Aug 7, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $7.44 | +61.29% | 13 | Oct 31, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Underweight | $7 → $8 | $11.89 | -32.72% | 15 | Oct 16, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $663.17 | -7.11% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $3.56 | +152.81% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $5.86 | -14.68% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $4.13 | +142.13% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $16.67 | +43.97% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $65.90 | +30.50% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $27.07 | +214.00% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $275 → $300 | $390.46 | -23.17% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $93 → $88 | $100.98 | -12.85% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $35.82 | -5.08% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $171.87 | -38.91% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $68.01 | -19.13% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $18.53 | -29.84% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $178.51 | -20.45% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $25.98 | -80.75% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $119.13 | -52.15% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $163.04 | -49.71% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $17.14 | +5.02% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $40.40 | -23.27% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $161.21 | +132.62% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $33.08 | -42.56% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $281.99 | +102.13% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $148.12 | -56.79% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $287.10 | +7.98% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $271.81 | +107.87% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $6.03 | +1,143.78% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $3.74 | +408.02% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $2.77 | +261.01% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $24.53 | +38.63% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $7.15 | +179.72% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $111.63 | +132.91% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $7.5 → $8
Current: $7.39
Upside: +8.25%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $7.44
Upside: +61.29%
Walgreens Boots Alliance
Oct 16, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $11.89
Upside: -32.72%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $663.17
Upside: -7.11%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $3.56
Upside: +152.81%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $5.86
Upside: -14.68%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $4.13
Upside: +142.13%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $16.67
Upside: +43.97%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $65.90
Upside: +30.50%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $27.07
Upside: +214.00%
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $390.46
Upside: -23.17%
May 5, 2023
Maintains: Equal-Weight
Price Target: $93 → $88
Current: $100.98
Upside: -12.85%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $35.82
Upside: -5.08%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $171.87
Upside: -38.91%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $68.01
Upside: -19.13%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $18.53
Upside: -29.84%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $178.51
Upside: -20.45%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $25.98
Upside: -80.75%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $119.13
Upside: -52.15%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $163.04
Upside: -49.71%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $17.14
Upside: +5.02%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $40.40
Upside: -23.27%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $161.21
Upside: +132.62%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $33.08
Upside: -42.56%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $281.99
Upside: +102.13%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $148.12
Upside: -56.79%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $287.10
Upside: +7.98%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $271.81
Upside: +107.87%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $6.03
Upside: +1,143.78%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $3.74
Upside: +408.02%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $2.77
Upside: +261.01%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $24.53
Upside: +38.63%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $7.15
Upside: +179.72%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $111.63
Upside: +132.91%